The US Food and Drug Administration (FDA) on Tuesday released a warning letter sent to Orange, CA-based distributor NuCare Pharmaceuticals after the company failed to correct certain drug listings.
The FDA said Walgreens has addressed violations related to drug listing deficiencies for one of its products, according to a Dec. 19 close-out letter. The agency previously cited Walgreens in ...
April 30 (Reuters) - The U.S. Food and Drug Administration on Thursday proposed excluding active ingredients for Novo Nordisk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results